Accuray Incorporated and University of Wisconsin-Madison Announce Collaboration to Advance Online Adaptive Radiotherapy for Cancer Care
Reuters
Sep 30, 2025
Accuray Incorporated and University of Wisconsin-Madison Announce Collaboration to Advance Online Adaptive Radiotherapy for Cancer Care
Accuray Incorporated and the University of Wisconsin School of Medicine and Public Health have announced the signing of a memorandum of understanding to advance online adaptive radiotherapy (OART) using Accuray's helical radiation treatment delivery platform. The collaboration aims to drive clinical research, education, and technology development to enhance the personalization and precision of cancer care. Building on the University of Wisconsin-Madison's history of innovation in radiation therapy, the partnership seeks to make advanced treatment options more accessible to clinical departments of all sizes, ultimately improving outcomes and quality of life for cancer patients.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accuray Incorporated published the original content used to generate this news brief via PR Newswire (Ref. ID: SF86565) on September 30, 2025, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.